NMTC
NeuroOne Medical Technologies Corporation
Price Chart
Latest Quote
$3.35
+0.10 (+3.08%)
Current Price
| Previous Close | $3.25 |
| Open | $3.24 |
| Day High | $3.35 |
| Day Low | $3.22 |
| Volume | 31,020 |
Stock Information
| Shares Outstanding | 8.70M |
| Total Debt | $207K |
| Cash Equivalents | $2.80M |
| Revenue | $12.72M |
| Net Income | $-6.64M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $29.15M |
| EPS (TTM) | $-0.89 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $26.28M |
| Sales | $12.72M |
| Income | $-6.64M |
| Book/sh | $0.62 |
| Cash/sh | $0.32 |
| Employees | 18 |
Financial Ratios
| Quick Ratio | 3.10 |
| Current Ratio | 4.38 |
| Debt/Eq | 3.85 |
Returns & Margins
| ROA | -71.68% |
| ROE | -204.44% |
| Gross Margin | 24.68% |
| Operating Margin | -87.86% |
| Profit Margin | -52.23% |
Ownership
| Insider Ownership | 15.12% |
| Institutional Ownership | 22.55% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -11.96 |
| P/S | 2.29 |
| P/B | 5.37 |
Analyst Data
| Recommendation | none |
| Target Price | $9.93 |
Technical Indicators
| SMA20 | $3.45 |
| SMA50 | $4.09 |
| SMA200 | $4.59 |
| RSI | 35.81 |
| ATR | 0.1989 |
| Shares Float | 7.84M |
| Short Float | 0.41% |
| Short Ratio | 0.94 |
| Volatility | 0.51 |
| Rel Volume | 1.07 |
Performance History
| Week | +0.90% |
| Month | -14.10% |
| Quarter | -27.49% |
| 6 Months | -22.02% |
| YTD | -34.47% |
| Year | -15.40% |
| 3 Years | -53.08% |
| 5 Years | -92.30% |
| 10 Years | -95.37% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $3.35 | 31,020 |
| 2026-06-22 | $3.25 | 45,500 |
| 2026-06-18 | $3.29 | 47,000 |
| 2026-06-17 | $3.31 | 17,700 |
| 2026-06-16 | $3.25 | 30,900 |
| 2026-06-15 | $3.32 | 14,800 |
| 2026-06-12 | $3.24 | 35,500 |
| 2026-06-11 | $3.24 | 30,200 |
| 2026-06-10 | $3.32 | 26,700 |
| 2026-06-09 | $3.39 | 24,400 |
| 2026-06-08 | $3.46 | 35,900 |
| 2026-06-05 | $3.44 | 20,900 |
| 2026-06-04 | $3.48 | 9,900 |
| 2026-06-03 | $3.47 | 22,600 |
| 2026-06-02 | $3.56 | 28,600 |
| 2026-06-01 | $3.72 | 30,300 |
| 2026-05-29 | $3.55 | 33,900 |
| 2026-05-28 | $3.72 | 30,100 |
| 2026-05-27 | $3.73 | 19,500 |
| 2026-05-26 | $3.87 | 46,100 |
About NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.
đ° Latest News
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ...
GuruFocus.com âĸ 2026-05-12T23:02:51ZNeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
GuruFocus.com âĸ 2026-02-17T21:01:47ZNeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-02-17T17:32:00Z
New Strong Buy Stocks for January 6th
Zacks âĸ 2026-01-06T10:33:00Z
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ...
GuruFocus.com âĸ 2025-12-19T01:00:25Z
We're Hopeful That NeuroOne Medical Technologies (NASDAQ:NMTC) Will Use Its Cash Wisely
Simply Wall St. âĸ 2025-11-06T10:42:50Z
Several Insiders Invested In NeuroOne Medical Technologies Flagging Positive News
Simply Wall St. âĸ 2025-09-26T11:45:42Z
NeuroOne gains FDA clearance for trigeminal nerve ablation
MedTech Dive âĸ 2025-08-20T11:12:36Z
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
Zacks âĸ 2025-08-19T14:13:00Z
NeuroOneâs nerve ablation system secures FDA clearance
Medical Device Network âĸ 2025-08-19T09:38:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,956,286 | $2,373,336 | $1,495,924 | $241,963 |
| Cost Of Revenue | $3,956,286 | $2,373,336 | $1,495,924 | $241,963 |
| Total Revenue | $9,097,692 | $3,453,003 | $1,952,441 | $171,169 |
| Operating Revenue | $9,097,692 | $3,453,003 | $1,952,441 | $171,169 |
| Expenses | ||||
| Interest Expense | $334,063 | $228,988 | $0 | $0 |
| Total Expenses | $13,324,165 | $15,340,212 | $13,907,691 | $10,201,934 |
| Other Income Expense | $955,162 | $-201,913 | $95,759 | $31,152 |
| Other Non Operating Income Expenses | $170,492 | $125,179 | $95,759 | $31,152 |
| Net Non Operating Interest Income Expense | $-334,063 | $-228,988 | $0 | $0 |
| Interest Expense Non Operating | $334,063 | $228,988 | $0 | $0 |
| Operating Expense | $9,367,879 | $12,966,876 | $12,411,767 | $9,959,971 |
| Other Operating Expenses | $-3,000,000 | - | $-1,455,188 | $-1,948,872 |
| General And Administrative Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Net Interest Income | $-334,063 | $-228,988 | $0 | $0 |
| Normalized Income | $-4,390,044 | $-11,991,018 | $-11,859,491 | $-9,999,613 |
| Net Income From Continuing And Discontinued Operation | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Total Operating Income As Reported | $-4,226,473 | $-11,887,209 | $-11,955,250 | $-10,030,765 |
| Net Income Common Stockholders | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Net Income | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Net Income Including Noncontrolling Interests | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Net Income Continuous Operations | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Pretax Income | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Operating Income | $-4,226,473 | $-11,887,209 | $-11,955,250 | $-10,030,765 |
| Gross Profit | $5,141,406 | $1,079,667 | $456,517 | $-70,794 |
| Special Income Charges | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.54 | $-2.76 | $-3.90 | $-3.78 |
| Basic EPS | $-0.54 | $-2.76 | $-3.90 | $-3.78 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,794,302 | $-11,515,239 | $-11,660,225 | $-9,912,145 |
| Total Unusual Items | $784,670 | $-327,092 | - | - |
| Total Unusual Items Excluding Goodwill | $784,670 | $-327,092 | - | - |
| Reconciled Depreciation | $261,679 | $246,791 | $199,266 | $118,620 |
| EBITDA (Bullshit earnings) | $-3,009,632 | $-11,842,331 | $-11,660,225 | $-9,912,145 |
| EBIT | $-3,271,311 | $-12,089,122 | $-11,859,491 | $-10,030,765 |
| Diluted Average Shares | $6,692,145 | $4,460,398 | $3,020,184 | $2,666,427 |
| Basic Average Shares | $6,692,145 | $4,460,398 | $3,020,184 | $2,666,427 |
| Diluted NI Availto Com Stockholders | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $784,670 | $-327,092 | - | - |
| Research And Development | $4,983,362 | $5,065,181 | $6,940,686 | $4,929,427 |
| Selling General And Administration | $7,384,517 | $7,901,695 | $6,926,269 | $6,979,416 |
| Other Gand A | - | - | - | - |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $7,027,576 | $754,751 | $6,159,827 | $9,492,472 |
| Total Assets | $10,785,647 | $5,369,940 | $8,097,314 | $12,822,609 |
| Total Non Current Assets | $559,363 | $739,015 | $784,389 | $646,846 |
| Goodwill And Other Intangible Assets | $44,946 | $67,262 | $89,577 | $111,892 |
| Current Assets | $10,226,284 | $4,630,925 | $7,312,925 | $12,175,763 |
| Current Deferred Assets | $22,920 | $142,633 | $0 | $0 |
| Prepaid Assets | $141,372 | $216,461 | $263,746 | $296,649 |
| Inventory | $2,226,805 | $2,635,153 | $1,726,686 | $704,538 |
| Receivables | $1,264,805 | $176,636 | $0 | $33,237 |
| Accounts Receivable | $1,264,805 | $176,636 | $0 | $33,237 |
| Cash Cash Equivalents And Short Term Investments | $6,570,382 | $1,460,042 | $5,322,493 | $11,141,339 |
| Cash And Cash Equivalents | $6,570,382 | $1,460,042 | $5,322,493 | $8,160,329 |
| Cash Financial | - | - | - | - |
| Debt | ||||
| Total Debt | $266,806 | $260,160 | $184,400 | $202,895 |
| Long Term Debt And Capital Lease Obligation | $143,148 | $194,392 | $55,284 | $119,556 |
| Current Debt And Capital Lease Obligation | $123,658 | $65,768 | $129,116 | $83,339 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,713,125 | $4,547,927 | $1,847,910 | $3,218,245 |
| Total Non Current Liabilities Net Minority Interest | $1,410,042 | $2,334,707 | $55,284 | $119,556 |
| Derivative Product Liabilities | $1,266,894 | $2,140,315 | $0 | - |
| Current Liabilities | $2,303,083 | $2,213,220 | $1,792,626 | $3,098,689 |
| Other Current Liabilities | $1,435 | $59,950 | - | - |
| Payables And Accrued Expenses | $2,177,990 | $2,087,502 | $1,663,510 | $1,560,162 |
| Payables | $1,010,369 | $1,029,206 | $685,104 | $927,662 |
| Accounts Payable | $1,010,369 | $1,029,206 | $685,104 | $927,662 |
| Current Deferred Liabilities | - | - | $0 | $1,455,188 |
| Equity | ||||
| Common Stock Equity | $7,072,522 | $822,013 | $6,249,404 | $9,604,364 |
| Total Equity Gross Minority Interest | $7,072,522 | $822,013 | $6,249,404 | $9,604,364 |
| Stockholders Equity | $7,072,522 | $822,013 | $6,249,404 | $9,604,364 |
| Retained Earnings | $-78,609,787 | $-75,004,413 | $-62,686,303 | $-50,826,812 |
| Other | ||||
| Ordinary Shares Number | $8,334,410 | $5,136,083 | $3,988,157 | $2,702,756 |
| Share Issued | $8,334,410 | $5,136,083 | $3,988,157 | $2,702,756 |
| Tangible Book Value | $7,027,576 | $754,751 | $6,159,827 | $9,492,472 |
| Invested Capital | $7,072,522 | $822,013 | $6,249,404 | $9,604,364 |
| Working Capital | $7,923,201 | $2,417,705 | $5,520,299 | $9,077,074 |
| Capital Lease Obligations | $266,806 | $260,160 | $184,400 | $202,895 |
| Total Capitalization | $7,072,522 | $822,013 | $6,249,404 | $9,604,364 |
| Additional Paid In Capital | $85,632,303 | $75,795,610 | $68,911,778 | $60,414,959 |
| Capital Stock | $50,006 | $30,816 | $23,929 | $16,217 |
| Common Stock | $50,006 | $30,816 | $23,929 | $16,217 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $143,148 | $194,392 | $55,284 | $119,556 |
| Current Capital Lease Obligation | $123,658 | $65,768 | $129,116 | $83,339 |
| Current Accrued Expenses | $1,167,621 | $1,058,296 | $978,406 | $632,500 |
| Net PPE | $514,417 | $671,753 | $694,812 | $534,954 |
| Accumulated Depreciation | $-798,823 | $-559,460 | $-334,984 | $-186,357 |
| Gross PPE | $1,313,240 | $1,231,213 | $1,029,796 | $721,311 |
| Other Properties | $255,195 | $254,910 | $169,059 | $719,416 |
| Machinery Furniture Equipment | $1,058,045 | $976,303 | $860,737 | $1,895 |
| Other Inventories | $871,492 | $877,065 | $1,202,778 | $400,063 |
| Finished Goods | $1,225,213 | $1,565,728 | $180,311 | $73,968 |
| Work In Process | $130,100 | $192,360 | $343,597 | $230,507 |
| Current Deferred Revenue | - | - | $0 | $1,455,188 |
| Other Short Term Investments | - | - | $0 | $2,981,010 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-2,919,014 | $-11,132,037 | $-13,270,991 | $-7,794,760 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,837,272 | $-11,011,840 | $-12,886,874 | $-7,519,534 |
| Cash Flow From Continuing Operating Activities | $-2,837,272 | $-11,011,840 | $-12,886,874 | $-7,519,534 |
| Operating Gains Losses | - | - | $32,143 | - |
| Investing Activities | ||||
| Capital Expenditure | $-81,742 | $-120,197 | $-384,117 | $-275,226 |
| Investing Cash Flow | $-81,742 | $-120,197 | $2,649,964 | $-3,244,765 |
| Cash Flow From Continuing Investing Activities | $-81,742 | $-120,197 | $2,649,964 | $-3,244,765 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-124,617 | $-81,403 | $-119,419 | $0 |
| Issuance Of Capital Stock | $9,614,037 | $5,870,683 | $8,590,156 | $13,350,582 |
| Financing Cash Flow | $8,029,354 | $7,269,586 | $7,399,074 | $12,023,282 |
| Cash Flow From Continuing Financing Activities | $8,029,354 | $7,269,586 | $7,399,074 | $12,023,282 |
| Net Other Financing Charges | $-1,529,816 | $-332,917 | $-1,071,663 | $-1,327,300 |
| Net Common Stock Issuance | $9,489,420 | $5,789,280 | $8,470,737 | $13,350,582 |
| Common Stock Issuance | $9,614,037 | $5,870,683 | $8,590,156 | $13,350,582 |
| Other | ||||
| End Cash Position | $6,570,382 | $1,460,042 | $5,322,493 | $8,160,329 |
| Beginning Cash Position | $1,460,042 | $5,322,493 | $8,160,329 | $6,901,346 |
| Changes In Cash | $5,110,340 | $-3,862,451 | $-2,837,836 | $1,258,983 |
| Proceeds From Stock Option Exercised | $69,750 | $1,813,223 | $0 | $0 |
| Common Stock Payments | $-124,617 | $-81,403 | $-119,419 | $0 |
| Net PPE Purchase And Sale | $-81,742 | $-120,197 | $-376,617 | $-275,226 |
| Purchase Of PPE | $-81,742 | $-120,197 | $-384,117 | $-275,226 |
| Change In Working Capital | $-429,191 | $-954,611 | $-2,428,510 | $1,213,563 |
| Change In Payables And Accrued Expense | $185,541 | $83,207 | $-1,472,502 | $1,950,255 |
| Change In Accrued Expense | $-54,442 | $16,214 | $-1,225,313 | $1,434,817 |
| Change In Payable | $239,983 | $66,993 | $-247,189 | $515,438 |
| Change In Account Payable | $239,983 | $66,993 | $-247,189 | $515,438 |
| Change In Prepaid Assets | $75,089 | $47,285 | $32,903 | $-145,540 |
| Change In Inventory | $398,348 | $-908,467 | $-1,022,148 | $-606,251 |
| Change In Receivables | $-1,088,169 | $-176,636 | $33,237 | $15,099 |
| Changes In Account Receivables | $-1,088,169 | $-176,636 | $33,237 | $15,099 |
| Other Non Cash Items | $-338,994 | $669,614 | $109,832 | $212,155 |
| Stock Based Compensation | $1,264,608 | $1,344,476 | $1,105,457 | $947,212 |
| Provisionand Write Offof Assets | $10,000 | $0 | - | - |
| Depreciation Amortization Depletion | $261,679 | $246,791 | $199,266 | $118,620 |
| Depreciation And Amortization | $261,679 | $246,791 | $199,266 | $118,620 |
| Amortization Cash Flow | $22,316 | $22,315 | $22,315 | $22,315 |
| Amortization Of Intangibles | $22,316 | $22,315 | $22,315 | $22,315 |
| Depreciation | $239,363 | $224,476 | $176,951 | $96,305 |
| Net Income From Continuing Operations | $-3,605,374 | $-12,318,110 | $-11,859,491 | $-9,999,613 |
| Net Investment Purchase And Sale | - | $0 | $3,026,581 | $-2,969,539 |
| Sale Of Investment | - | $0 | $4,500,000 | $500,000 |
| Purchase Of Investment | - | $0 | $-1,473,419 | $-3,469,539 |
| Sale Of PPE | - | $0 | $7,500 | $0 |
| Amortization Of Securities | - | $0 | $-45,571 | $-11,471 |
| Gain Loss On Sale Of PPE | - | $0 | $32,143 | $0 |
| Issuance Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-19